Baliospermum solanifolium (Burm.) Suresh (syn. B. montanum): A critical evidence audit of diterpenoid chemistry, pharmacology, safety and translational constraints.

Alok S

Open source

DOI
10.1016/j.fitote.2026.107537
Published
2026 Oct 30
Container
Fitoterapia
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.fitote.2026.107537,
  title = {Baliospermum solanifolium (Burm.) Suresh (syn. B. montanum): A critical evidence audit of diterpenoid chemistry, pharmacology, safety and translational constraints.},
  author = {Alok S},
  year = {2026},
  journal = {Fitoterapia},
  doi = {10.1016/j.fitote.2026.107537},
  url = {https://doi.org/10.1016/j.fitote.2026.107537}
}

RIS

TY  - JOUR
TI  - Baliospermum solanifolium (Burm.) Suresh (syn. B. montanum): A critical evidence audit of diterpenoid chemistry, pharmacology, safety and translational constraints.
AU  - Alok S
PY  - 2026
JO  - Fitoterapia
DO  - 10.1016/j.fitote.2026.107537
UR  - https://doi.org/10.1016/j.fitote.2026.107537
ER  - 

APA

S, A. (2026). Baliospermum solanifolium (Burm.) Suresh (syn. B. montanum): A critical evidence audit of diterpenoid chemistry, pharmacology, safety and translational constraints.. Fitoterapia. https://doi.org/10.1016/j.fitote.2026.107537

Source records